Genflow Biosciences (STU:WQ5) Total Liabilities : €0.58 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Genflow Biosciences Total Liabilities?

Genflow Biosciences's Total Liabilities for the quarter that ended in Jun. 2024 was €0.58 Mil.

Genflow Biosciences's quarterly Total Liabilities increased from Jun. 2023 (€0.23 Mil) to Dec. 2023 (€0.40 Mil) and increased from Dec. 2023 (€0.40 Mil) to Jun. 2024 (€0.58 Mil).

Genflow Biosciences's annual Total Liabilities increased from Dec. 2021 (€0.26 Mil) to Dec. 2022 (€0.29 Mil) and increased from Dec. 2022 (€0.29 Mil) to Dec. 2023 (€0.40 Mil).

Genflow Biosciences Total Liabilities Historical Data

The historical data trend for Genflow Biosciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences Total Liabilities Chart

Genflow Biosciences Annual Data

Trend

Dec21

Dec22

Dec23

Total Liabilities

0.26

0.29

0.40

Genflow Biosciences Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Liabilities	Get a 7-Day Free Trial			0.17	0.29	0.23	0.40	0.58

Genflow Biosciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Genflow Biosciences's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.402	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	0.40

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1.244	-	0.843
	=	0.40

Genflow Biosciences's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0.583	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	0.58

Total Liabilities	=	Total Assets (Q: Jun. 2024 )	-	Total Equity (Q: Jun. 2024 )
	=	1.597	-	1.014
	=	0.58

Genflow Biosciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Genflow Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (STU:WQ5) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

GENFF:USA GENF:UK

Address

6 Heddon Street, London, GBR, W1B 4BT

Website

https://www.genflowbio.com

Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

Genflow Biosciences Headlines

No Headlines